Skip to content

Neural mechanisms of psychedelic visual imagery.

Devon Stoliker, Katrin H Preller, Leonardo Novelli, Alan Anticevic, Gary F Egan, Franz X Vollenweider, Adeel Razi

Molecular psychiatry April 1, 2025 DOI: 10.1038/s41380-024-02632-3 via PubMed

Summary

AI-generated from the abstract

Psilocybin, the active compound in magic mushrooms, alters visual perception by changing how brain regions communicate. Under psilocybin, early visual areas and higher visual-association regions showed increased self-inhibition, reducing sensitivity to incoming neural signals. At the same time, top-down feedback from visual-association areas to earlier visual regions was enhanced. This shift in balance—less bottom-up sensitivity and stronger top-down influence—may explain the vivid eyes-closed imagery characteristic of psychedelic experiences. The findings come from a double-blind, placebo-controlled study of 24 healthy adults using functional MRI and dynamic causal modeling, and they advance understanding of both basic visual perception and potential clinical applications.

Study at a glance

Characteristics Double-blind, randomised, placebo-controlled, cross-over study Randomized Peer reviewed
Sample size 24
Population Healthy adults
Intervention Psilocybin
Dose 0.2 mg/kg
Topics Psilocybin
Keywords Psychedelics Neuroscience Brain imaging Visual perception
Citations 19
Key finding Psilocybin increased self-inhibition of early visual and higher visual-association regions and reduced inhibition from visual-association areas to earlier visual areas, suggesting enhanced top-down connectivity contributes to eyes-closed visual imagery.

Abstract

Visual alterations under classic psychedelics can include rich phenomenological accounts of eyes-closed imagery. Preclinical evidence suggests agonism of the 5-HT2A receptor may reduce synaptic gain to produce psychedelic-induced imagery. However, this has not been investigated in humans. To infer the directed connectivity changes to visual connectivity underlying psychedelic visual imagery in healthy adults, a double-blind, randomised, placebo-controlled, cross-over study was performed, and dynamic causal modelling was applied to the resting state eyes-closed functional MRI scans of 24 subjects after administration of 0.2 mg/kg of the serotonergic psychedelic drug, psilocybin (magic mushrooms), or placebo. The effective connectivity model included the early visual area, fusiform gyrus, intraparietal sulcus, and inferior frontal gyrus. We observed a pattern of increased self-inhibition of both early visual and higher visual-association regions under psilocybin that was consistent with preclinical findings. We also observed a pattern of reduced inhibition from visual-association regions to earlier visual areas that indicated top-down connectivity is enhanced during visual imagery. The results were analysed with behavioural measures taken immediately after the scans, suggesting psilocybin-induced decreased sensitivity to neural inputs is associated with the perception of eyes-closed visual imagery. The findings inform our basic and clinical understanding of visual perception. They reveal neural mechanisms that, by affecting balance, may increase the impact of top-down feedback connectivity on perception, which could contribute to the visual imagery seen with eyes-closed during psychedelic experiences.

Explore topics

Comments

No comments yet.

Log in to comment